Lessons from the pandemic : Responding to emerging zoonotic viral diseases-a Keystone Symposia report
© 2022 New York Academy of Sciences..
The COVID-19 pandemic caught the world largely unprepared, including scientific and policy communities. On April 10-13, 2022, researchers across academia, industry, government, and nonprofit organizations met at the Keystone symposium "Lessons from the Pandemic: Responding to Emerging Zoonotic Viral Diseases" to discuss the successes and challenges of the COVID-19 pandemic and what lessons can be applied moving forward. Speakers focused on experiences not only from the COVID-19 pandemic but also from outbreaks of other pathogens, including the Ebola virus, Lassa virus, and Nipah virus. A general consensus was that investments made during the COVID-19 pandemic in infrastructure, collaborations, laboratory and manufacturing capacity, diagnostics, clinical trial networks, and regulatory enhancements-notably, in low-to-middle income countries-must be maintained and strengthened to enable quick, concerted responses to future threats, especially to zoonotic pathogens.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:1518 |
---|---|
Enthalten in: |
Annals of the New York Academy of Sciences - 1518(2022), 1 vom: 08. Dez., Seite 209-225 |
Sprache: |
Englisch |
---|
Links: |
---|
Themen: |
COVID-19 |
---|
Anmerkungen: |
Date Completed 15.12.2022 Date Revised 31.03.2023 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1111/nyas.14898 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM346987989 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM346987989 | ||
003 | DE-627 | ||
005 | 20231226032747.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1111/nyas.14898 |2 doi | |
028 | 5 | 2 | |a pubmed24n1156.xml |
035 | |a (DE-627)NLM346987989 | ||
035 | |a (NLM)36183296 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Cable, Jennifer |e verfasserin |4 aut | |
245 | 1 | 0 | |a Lessons from the pandemic |b Responding to emerging zoonotic viral diseases-a Keystone Symposia report |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 15.12.2022 | ||
500 | |a Date Revised 31.03.2023 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022 New York Academy of Sciences. | ||
520 | |a The COVID-19 pandemic caught the world largely unprepared, including scientific and policy communities. On April 10-13, 2022, researchers across academia, industry, government, and nonprofit organizations met at the Keystone symposium "Lessons from the Pandemic: Responding to Emerging Zoonotic Viral Diseases" to discuss the successes and challenges of the COVID-19 pandemic and what lessons can be applied moving forward. Speakers focused on experiences not only from the COVID-19 pandemic but also from outbreaks of other pathogens, including the Ebola virus, Lassa virus, and Nipah virus. A general consensus was that investments made during the COVID-19 pandemic in infrastructure, collaborations, laboratory and manufacturing capacity, diagnostics, clinical trial networks, and regulatory enhancements-notably, in low-to-middle income countries-must be maintained and strengthened to enable quick, concerted responses to future threats, especially to zoonotic pathogens | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a COVID-19 | |
650 | 4 | |a Ebola virus | |
650 | 4 | |a Lassa virus | |
650 | 4 | |a Nipah virus | |
650 | 4 | |a infectious diseases | |
650 | 4 | |a vaccines | |
650 | 4 | |a zoonotic diseases | |
700 | 1 | |a Fauci, Anthony |e verfasserin |4 aut | |
700 | 1 | |a Dowling, William E |e verfasserin |4 aut | |
700 | 1 | |a Günther, Stephan |e verfasserin |4 aut | |
700 | 1 | |a Bente, Dennis A |e verfasserin |4 aut | |
700 | 1 | |a Yadav, Pragya Dhruv |e verfasserin |4 aut | |
700 | 1 | |a Madoff, Lawrence C |e verfasserin |4 aut | |
700 | 1 | |a Wang, Lin-Fa |e verfasserin |4 aut | |
700 | 1 | |a Arora, Rahul K |e verfasserin |4 aut | |
700 | 1 | |a Van Kerkhove, Maria |e verfasserin |4 aut | |
700 | 1 | |a Chu, May C |e verfasserin |4 aut | |
700 | 1 | |a Jaenisch, Thomas |e verfasserin |4 aut | |
700 | 1 | |a Epstein, Jonathan H |e verfasserin |4 aut | |
700 | 1 | |a Frost, Simon David William |e verfasserin |4 aut | |
700 | 1 | |a Bausch, Daniel G |e verfasserin |4 aut | |
700 | 1 | |a Hensley, Lisa E |e verfasserin |4 aut | |
700 | 1 | |a Bergeron, Éric |e verfasserin |4 aut | |
700 | 1 | |a Sitaras, Ioannis |e verfasserin |4 aut | |
700 | 1 | |a Gunn, Michael D |e verfasserin |4 aut | |
700 | 1 | |a Geisbert, Thomas W |e verfasserin |4 aut | |
700 | 1 | |a Muñoz-Fontela, César |e verfasserin |4 aut | |
700 | 1 | |a Krammer, Florian |e verfasserin |4 aut | |
700 | 1 | |a de Wit, Emmie |e verfasserin |4 aut | |
700 | 1 | |a Nordenfelt, Pontus |e verfasserin |4 aut | |
700 | 1 | |a Saphire, Erica Ollmann |e verfasserin |4 aut | |
700 | 1 | |a Gilbert, Sarah C |e verfasserin |4 aut | |
700 | 1 | |a Corbett, Kizzmekia S |e verfasserin |4 aut | |
700 | 1 | |a Branco, Luis M |e verfasserin |4 aut | |
700 | 1 | |a Baize, Sylvain |e verfasserin |4 aut | |
700 | 1 | |a van Doremalen, Neeltje |e verfasserin |4 aut | |
700 | 1 | |a Krieger, Marco A |e verfasserin |4 aut | |
700 | 1 | |a Clemens, Sue Ann Costa |e verfasserin |4 aut | |
700 | 1 | |a Hesselink, Renske |e verfasserin |4 aut | |
700 | 1 | |a Hartman, Dan |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Annals of the New York Academy of Sciences |d 1945 |g 1518(2022), 1 vom: 08. Dez., Seite 209-225 |w (DE-627)NLM000012823 |x 1749-6632 |7 nnns |
773 | 1 | 8 | |g volume:1518 |g year:2022 |g number:1 |g day:08 |g month:12 |g pages:209-225 |
856 | 4 | 0 | |u http://dx.doi.org/10.1111/nyas.14898 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 1518 |j 2022 |e 1 |b 08 |c 12 |h 209-225 |